Adequan Canine Joint Injection from Japan
Polysulfated glycosaminoglycan injections for canine osteoarthritis, in pre-filled syringes. Disease-modifying veterinary therapeutic classified HTS 3004.90.92.01.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Rx-only status requires CVM approval verification
• Sterility certificates mandatory for injectables
• Not nutritional supplements despite joint health claims